000 01759nam  2200313za 4500
0019.837516
003CaOODSP
00520221107151146
007cr |||||||||||
008170601s2018    onc     o    f000 0 eng d
020 |a9780660086842
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH169-6/2017E-PDF
24500|aOpioid medicines |h[electronic resource] : |binformation for patients and families.
260 |a[Ottawa] : |bHealth Canada, |c2018.
300 |a[1] p.
500 |aIssued also in French under title: Médicaments opioïdes : renseignements pour les patients et les familles.
500 |aCaption title.
500 |a"Date: 2018/05/02."
500 |aIssued also in HTML format.
520 |a"Health Canada has identified the need for patients to receive clear information about the safe use of opioids and the risks associated with their use. As such, requirements have been added, under the Food and Drug Regulations, for a warning sticker and patient information handout to be provided with all prescription opioids that appear in Part A of the "List of Opioids", at the time of dispensing. The handout provides information about the safe use of opioids and the risks associated with their use"--Provided by publisher.
693 4|aOpioids
693 4|aPrescription drugs
7101 |aCanada. |bHealth Canada.
77508|tMédicaments opioïdes |w(CaOODSP)9.837518
85640|qPDF|s363 KB|uhttps://publications.gc.ca/collections/collection_2018/sc-hc/H169-6-2017-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/policies/warning-sticker-opioid-patient-information-handout/information-handout.html